Kauser M. Akhoon

Array ( [id] => 15797295 [patent_doc_number] => 20200121790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => NEAR-IR LIGHT-CLEAVABLE CONJUGATES AND CONJUGATE PRECURSORS [patent_app_type] => utility [patent_app_number] => 16/723482 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14452493 [patent_doc_number] => 10322193 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-06-18 [patent_title] => Immunoconjugates with an intracellularly-cleavable linkage [patent_app_type] => utility [patent_app_number] => 16/276173 [patent_app_country] => US [patent_app_date] => 2019-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24945 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16276173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14196657 [patent_doc_number] => 10265414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-23 [patent_title] => Immunoconjugates with an intracellularly-cleavable linkage [patent_app_type] => utility [patent_app_number] => 16/045400 [patent_app_country] => US [patent_app_date] => 2018-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24961 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14018951 [patent_doc_number] => 20190071469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-07 [patent_title] => THERAPEUTIC PEPTIDOMIMETIC MACROCYCLES [patent_app_type] => utility [patent_app_number] => 16/023606 [patent_app_country] => US [patent_app_date] => 2018-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31095 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15308881 [patent_doc_number] => 10519131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Benzazepine compounds, conjugates, and uses thereof [patent_app_type] => utility [patent_app_number] => 15/973506 [patent_app_country] => US [patent_app_date] => 2018-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 57593 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 427 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15973506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13309901 [patent_doc_number] => 20180206487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => ANTI-INFECTIVE PROTECTOR [patent_app_type] => utility [patent_app_number] => 15/918244 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15918244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12675973 [patent_doc_number] => 20180117157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => STABLE PHARMACEUTICAL COMPOSITION, COMPRISING AN AQUEOUS SOLUTION OF AN ANTIBODY-DERIVED THERAPEUTICALLY ACTIVE PROTEIN [patent_app_type] => utility [patent_app_number] => 15/854434 [patent_app_country] => US [patent_app_date] => 2017-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15854434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15070831 [patent_doc_number] => 10464890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => PGAM1 inhibitors and methods related thereto [patent_app_type] => utility [patent_app_number] => 15/847670 [patent_app_country] => US [patent_app_date] => 2017-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 93 [patent_no_of_words] => 22712 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15847670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12606729 [patent_doc_number] => 20180094073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => ANTI-TROP2 ANTIBODY-DRUG CONJUGATE [patent_app_type] => utility [patent_app_number] => 15/821662 [patent_app_country] => US [patent_app_date] => 2017-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45573 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12238540 [patent_doc_number] => 20180071403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'ANTIBODY-DRUG CONJUGATE PRODUCED BY BINDING THROUGH LINKER HAVING HYDROPHILIC STRUCTURE' [patent_app_type] => utility [patent_app_number] => 15/821697 [patent_app_country] => US [patent_app_date] => 2017-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 103548 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15694451 [patent_doc_number] => 10603387 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-31 [patent_title] => Duocarmycin ADCs showing improved in vivo antitumor activity [patent_app_type] => utility [patent_app_number] => 15/798695 [patent_app_country] => US [patent_app_date] => 2017-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6180 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15798695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12702493 [patent_doc_number] => 20180125997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF [patent_app_type] => utility [patent_app_number] => 15/786055 [patent_app_country] => US [patent_app_date] => 2017-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37202 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15786055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15510325 [patent_doc_number] => 10561729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Near-IR light-cleavable conjugates and conjugate precursors [patent_app_type] => utility [patent_app_number] => 16/323747 [patent_app_country] => US [patent_app_date] => 2017-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 17644 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12217568 [patent_doc_number] => 20180055928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => 'Tumor specific oligosaccharide epitopes and use thereof' [patent_app_type] => utility [patent_app_number] => 15/653546 [patent_app_country] => US [patent_app_date] => 2017-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26760 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15653546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15008291 [patent_doc_number] => 10450260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-22 [patent_title] => NO- and H [patent_app_type] => utility [patent_app_number] => 15/605195 [patent_app_country] => US [patent_app_date] => 2017-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 39 [patent_no_of_words] => 20816 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12543024 [patent_doc_number] => 10010542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => PFKFB3 inhibit and methods of use as an anti-cancer therapeutic [patent_app_type] => utility [patent_app_number] => 15/482956 [patent_app_country] => US [patent_app_date] => 2017-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7726 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15482956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13091263 [patent_doc_number] => 10064957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-04 [patent_title] => Immunoconjugates with an intracellularly-cleavable linkage [patent_app_type] => utility [patent_app_number] => 15/587526 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24920 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12057225 [patent_doc_number] => 20170333567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers' [patent_app_type] => utility [patent_app_number] => 15/461569 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 65277 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12057225 [patent_doc_number] => 20170333567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers' [patent_app_type] => utility [patent_app_number] => 15/461569 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 65277 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11704636 [patent_doc_number] => 20170173134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'IMMUNOMODULATOR FOR THE TREATMENT OF CANCEROUS AND PRECANCEROUS LESIONS IN THE EPITHELIAL TISSUE LINING SURFACES INSIDE OR OUTSIDE BODY ORGANS' [patent_app_type] => utility [patent_app_number] => 15/443564 [patent_app_country] => US [patent_app_date] => 2017-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31571 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443564 [rel_patent_id] =>[rel_patent_doc_number] =>)